Skip to main content

2 Result(s)

within A Yeramian Remove this filter

and

  1. No Access

    Article

    Endometrial carcinoma: molecular alterations involved in tumor development and progression

    In the western world, endometrial carcinoma (EC) is the most common cancer of the female genital tract. The annual incidence has been estimated at 10–20 per 100 000 women. Two clinicopathological variants are ...

    A Yeramian, G Moreno-Bueno, X Dolcet, L Catasus, M Abal, E Colas, J Reventos… in Oncogene (2013)

  2. No Access

    Article

    CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

    Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a promising antineoplastic agent because of its ability to selectively kill tumoral cells. However, some cancer cells are resistan...

    D Llobet, N Eritja, M Encinas, N Llecha, A Yeramian, J Pallares, A Sorolla… in Oncogene (2008)